Longevity Health Holdings Inc. (XAGE) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 1 wire item for XAGE, including 1 press release or news item. The most recent was published Nov 11, 2026.
News · 26 weeks13+100%
2026-05-172026-11-08
Mix1290d
- SEC Filings9(75%)
- Other3(25%)
Activity · 52 weeks2514 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- PRLongevity Health Holdings Announces Exploration of Strategic AlternativesPITTSBURGH, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") today announced that its Board of Directors (the "Board") is exploring and evaluating strategic alternatives for the Company’s bio-aesthetic and therapeutic businesses to maximize value for the Company and its stakeholders. As part of this process, Longevity intends to evaluate a range of potential transactions, including, but not limited to, a merger, reverse merger or other business combination; a sale or license of one or more of the Company’s businesses or assets; a strategic partnership; or other transactions. "With the Puritan Partners litigation settled, now is
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRLongevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross ProceedsPITTSBURGH, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") today announced that it has entered into a Securities Purchase Agreement with Puritan Partners LLC ("Puritan") providing for up to $625,000 in aggregate gross proceeds to the Company through a series of 10% senior secured convertible notes, each issued with a 10% original issue discount (the "Purchase Agreement"). "We’re pleased to deepen our relationship with Puritan Partners through this new facility, which gives Longevity additional financial flexibility as we continue to build out our regenerative bio-aesthetics platform and pursue other strategic opportunities,"
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRLongevity Health Holdings Announces Settlement of Litigation with Puritan Partners LLCSettlement resolves litigation pending since November 2023 that had constrained the Company's access to capital and to pursue strategic opportunities PITTSBURGH, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company"), a bio-aesthetics company focused on human longevity and healthy aging, today announced that it has entered into a settlement agreement (the "Settlement Agreement") with Puritan Partners LLC ("Puritan") fully resolving the litigation captioned Puritan Partners LLC v. Carmell Regen Med Corporation, et al., Index No. 655566/2023, pending in the Supreme Court of the State of New York, County of New York (the "Action"). Puri
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 10-Q filed by Longevity Health Holdings Inc.10-Q - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form SCHEDULE 13D filed by Longevity Health Holdings Inc.SCHEDULE 13D - Longevity Health Holdings, Inc. (0001842939) (Subject)
- INSIDERSEC Form 4 filed by Ajjarapu J. Ram4 - Longevity Health Holdings, Inc. (0001842939) (Issuer)
- INSIDERSEC Form 3 filed by new insider Ajjarapu J. Ram3 - Longevity Health Holdings, Inc. (0001842939) (Issuer)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 10-K filed by Longevity Health Holdings Inc.10-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- PRLongevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused GrowthPITTSBURGH, March 17, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB:XAGE) ("Longevity" or the "Company") announced that its Board of Directors has appointed Ram Ajjarapu as Chairman and Chief Executive Officer, effective as of March 16, 2026. "Ram brings a strong track record of scaling businesses and executing value-creating transactions," said Rajiv Shukla, outgoing Chairman and Chief Executive Officer. "We look forward to his leadership as Longevity seeks to advance its growth strategy through acquisitions as a public company." "I am excited to join Longevity and help build the Company's acquisition platform," said Mr. Ajjarapu. "My investment and leadership commitme
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECLongevity Health Holdings Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement8-K - Longevity Health Holdings, Inc. (0001842939) (Filer)
- SECSEC Form 25-NSE filed by Longevity Health Holdings Inc.25-NSE - Longevity Health Holdings, Inc. (0001842939) (Subject)
- SECSEC Form 424B3 filed by Longevity Health Holdings Inc.424B3 - Longevity Health Holdings, Inc. (0001842939) (Filer)
XAGE FAQ
6 questionsWhat is the latest news on XAGE?
In the last 30 days Quantisnow tracked 1 wire item for XAGE: 1 press release or news item. The most recent was published on November 11, 2026.Where does XAGE stock trade?
Longevity Health Holdings Inc. (XAGE) is listed on NASDAQ.What sector and industry is XAGE in?
Longevity Health Holdings Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Longevity Health Holdings Inc. go public?
Longevity Health Holdings Inc. (XAGE) completed its IPO in 2021.What companies are similar to XAGE?
Notable peers in the same industry include MMM (3M Company), DXCM (DexCom Inc.), SYK (Stryker Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare XAGE side-by-side with any of them on Quantisnow.How can I track XAGE on Quantisnow?
Quantisnow aggregates Longevity Health Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow XAGE to receive live email and push alerts on every new disclosure.